• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS1900921 二甲双胍恩格列净片(Ⅰ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2020-01-22 杭州中美华东制药有限公司 Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd In Review 2020-01-21 view
JYHB2000467 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-04-22 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-05-14 view
JYHB2000468 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-04-22 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-05-14 view
JYHB2000704 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-06-16 view
JYHB2000705 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-06-16 view
JYHB2000798 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-07 view
JYHB2000799 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-07 view
JYHB2001001 二甲双胍恩格列净片(Ⅳ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-07-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-08-21 view
JYHB2001000 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-07-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-08-21 view
JYHB2002594 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-12-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-01-08 view
JYHB2002593 二甲双胍恩格列净片(Ⅴ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-12-18 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2021-01-08 view
JYHB2101090 二甲双胍恩格列净片(Ⅵ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2021-05-11 Boehringer Ingelheim International GmbH view
JYHB2101089 二甲双胍恩格列净片(Ⅴ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2021-05-11 Boehringer Ingelheim International GmbH view
CYHB2102261 二甲双胍恩格列净片(Ⅰ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Supplementary Application 2021-12-08 Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
CYHS2201161 二甲双胍恩格列净片(Ⅰ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2022-07-28 view
CYHS2201179 二甲双胍恩格列净片(Ⅰ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2022-08-01 view
JYHB2200427 二甲双胍恩格列净片(Ⅴ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view
JYHB2200428 二甲双胍恩格列净片(ⅤI) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view
JYHB2200425 二甲双胍恩格列净片(III) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view
JYHB2200426 二甲双胍恩格列净片(IV) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2022-08-08 Boehringer Ingelheim International GmbH view